EZH2, a histone methyltransferase in the human genome, catalyzes the lysine trimethylation of histone 3 at position 27 (H3K27me3), which leads to the silencing of its target genes involved in cell proliferation, cell differentiation, and cancer development [16,17]. Here, EZH2 is linked to cancer.